Blue Cross Blue Shield - South Carolina Prior Authorization Lookup
- Blue Cross Blue Shield - South Carolina coverage criteria
- All Blue Cross Blue Shield - South Carolina policy updates
Latest Blue Cross Blue Shield - South Carolina prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2026-08-01Actimmune (interferon gamma-1b) and related specialty drug prior authorization criteria (partial)Portion of the payer's specialty drug prior authorization criteria listing products (including Actimmune and several biologics) with indications, required medical information, prescriber and coverage-duration rules affecting providers submitting PA requests for these products.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-01Actimmune (interferon gamma-1b) — Prior Authorization and Coverage CriteriaThis policy governs prior authorization, coverage criteria, and utilization controls for Actimmune (INJ 100MCG/0.5ML) for medically accepted indications (chronic granulomatous disease and severe malignant osteopetrosis) for Blue Cross Blue Shield - South Carolina members and providers.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-012026 Pdp Pa CriteriaPart D prior authorization criteria for multiple drugs/products, specifying indications, required medical information, prescriber restrictions, coverage durations, prerequisite Part D drug requirements, age restrictions, and other criteria for initial and reauthorization approvals. This extraction covers Part 1 of 12 of the full document.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-01Formulary step therapy and prior authorization criteria for selected psychiatric and related drugsThis document governs step therapy and trial-of-therapy criteria for specific outpatient prescription products (primarily psychiatric medications and related agents) under the South Carolina PDP Basic plan; it affects prescribers and pharmacy benefit adjudication for plan members in South Carolina.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01BlueCross Total Prescription Drug Formulary — Coverage CriteriaThis document is the BlueCross Total prescription drug formulary for BlueCross BlueShield of South Carolina describing covered drugs, restrictions (prior authorization, quantity limits, step therapy), tiered cost sharing, and how members and providers can request exceptions; it affects plan members and prescribing providers.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01Drug coverage and step therapy rules (partial index)Portion of the payer's pharmacy coverage document listing affected products and step/step-therapy criteria for selected specialty and non-specialty drugs; intended for providers and pharmacy staff applying prior authorization and step edits for Blue Cross Blue Shield - South Carolina members.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01Drug-specific medical necessity and prior authorization criteria (partial list)This section summarizes outpatient specialty drug coverage criteria, required documentation, prescriber and age restrictions, prerequisite therapy and reauthorization rules for BCBS‑SC members.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-01Drug-specific prior authorization criteria for specialty medicationsThis document lists coverage criteria, prescriber restrictions, required medical information, coverage durations, and prerequisite therapy rules for specialty and Part D prescription products; it applies to providers requesting benefit coverage or authorization for the listed products.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01Actinic Keratosis - Score (Diclofenac Sodium GEL 3% and related step therapy policies)Defines product-specific utilization management (step therapy) requirements for actinic keratosis topical therapy (Diclofenac Sodium GEL 3%) and several listed specialty drugs; impacts prescribers and pharmacy prior authorization reviewers.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01Blue Retiree Rx 2026 Formulary (Drug List) — Coverage CriteriaThis document is the 2026 formulary (Drug List) for Blue Retiree Rx and describes which prescription drugs are covered, who to contact, and the plan rules (prior authorization, quantity limits, step therapy, tiering and cost-sharing) that apply to members of the Blue Retiree Rx plan.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01BlueCross Total Prescription Drug Formulary — Coverage CriteriaGoverns the prescription drug formulary (Drug List) for BlueCross Total Medicare plan members, describing coverage, restrictions, and member options including prior authorization, step therapy, quantity limits, and exceptions. Affects plan members and prescribers using the BlueCross Total network pharmacies.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01BlueCross Total Value 2026 Formulary — Drug List and Requirements/LimitsGoverns the BlueCross Total Value 2026 prescription drug formulary and rules for coverage, prior authorization, quantity limits, step therapy, and exceptions for plan members and prescribers.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-04-01Formulary step therapy and prior authorization rules for selected drugsLists step therapy and prior authorization criteria for specific formulary products and applies to Blue Cross Blue Shield - South Carolina members and providers managing these drugs.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-01ACTINIC KERATOSIS - SCORE (Step Therapy Criteria)This document lists step therapy requirements and affected products for several drug classes and specific medications for Blue Cross Blue Shield - South Carolina members. It governs prior authorization/step edits for drugs such as diclofenac gel, various antidepressants, atypical antipsychotics, Invega Hafyera, Relistor, and Rytary.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-01BlueCross Total Medicare Part D Formulary — Coverage CriteriaThis document is the BlueCross Total (BlueCross BlueShield of South Carolina) Medicare Part D formulary describing covered drugs, coverage rules, restrictions (prior authorization, step therapy, quantity limits), and how members can request exceptions. It affects plan members, prescribers, and network pharmacies using BlueCross Total prescription drug benefits.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-01Formulary step-therapy and prior authorization criteria for selected pharmacy productsThis document lists prior authorization/step therapy requirements and continuation rules for several outpatient prescription drugs on the Blue Cross Blue Shield - South Carolina formulary. It affects prescribers and pharmacy benefit administrators managing new starts and continuations for the listed products.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-01South Carolina PDP Basic - Formulary step and trial requirementsThis document lists products on the South Carolina PDP Basic formulary and specific prior-authorization or step-therapy trial requirements that govern coverage and continuation of therapy for members and their providers.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-03-01Specialty drug prior authorization and medical necessity criteria (immunology/rheumatology and other specialties)Defines coverage, prior authorization requirements, clinical criteria, prescriber restrictions, age limits, coverage durations, and prerequisite therapy policies for multiple specialty medications on the Blue Cross Blue Shield - South Carolina formulary; affects providers requesting coverage for listed products.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2026-01-01Adalimumab and selected specialty drugs — coverage criteriaThis document governs medical benefit coverage criteria, prescriber requirements, prior authorization details, and coverage durations for multiple specialty drugs (including adalimumab products) for Blue Cross Blue Shield - South Carolina members.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-01Drug coverage criteria for specialty/immunology medications (partial list)This document section lists products and their coverage criteria (indications, required medical information, prescriber restrictions, coverage duration, and other criteria) affecting Blue Cross Blue Shield - South Carolina members for the named specialty medications in the immunology/rheumatology area. It applies to benefits and providers seeking prior authorization for these products.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2025-12-01Pharmacy & Specialty Drugs — Coverage Criteria (Formulary ID 25385, Version 18)This document lists coverage criteria, required medical information, prescriber restrictions, and coverage durations for multiple pharmacy and specialty drugs under the Blue Cross Blue Shield - South Carolina formulary; it affects providers submitting prior authorizations for the listed products.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2025-11-01Formulary step therapy and prior authorization criteria for selected outpatient drugsDefines step-therapy and trial-of-therapy requirements for specific outpatient pharmacy products (Formulary ID 25385); affects pharmacy providers and prescribers requesting coverage for the listed drugs and titration packs.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2025-11-01Formulary step therapy and prior authorization criteria for selected psychotropic and related drugsAll Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2025-11-01Formulary step therapy and prior authorization requirements — Behavioral health agentsLists products subject to step therapy or prior trials and the specific trial requirements for approval; affects prescribers and pharmacy benefit administrators for Blue Cross Blue Shield - South Carolina members. Covers antidepressants, atypical antipsychotics, select CNS agents, and other listed products.All Blue Cross Blue Shield - South Carolina updates
- Prior AuthClinical/Medical PolicyEff. 2025-11-01Formulary step therapy requirements for select prescription drugsThis document lists product-specific prior authorization/step therapy criteria for Blue Cross Blue Shield - South Carolina Bronze 6T members, describing required trials of alternative agents for various branded and specialty drugs.All Blue Cross Blue Shield - South Carolina updates
1–25 of 94
1 / 4
Tool Description
Search Blue Cross Blue Shield - South Carolinaprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Type a drug name (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee”), or a policy title into the search bar. Filter results by payer, specialty, policy type, or effective year. Open any result for the full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Published by
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.